23 January 2014 - Deborah Wilkes
Archived
Johnson & Johnson's OTC sales in the US increased by 19.7% to US$1.29 billion in 2013, as the company continued to return its recalled products to shelves.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.